Genomic testing for cancer of unknown primary
Treatments studied
Part of Cancer clinical trials.
This trial is for people with cancer of unknown primary (CUP), meaning cancer that started in an unknown place in the body. It aims to use advanced genomic testing (looking at your tumor's DNA) on your stored tumor sample and blood to find clues about where the cancer began and possible treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years old or older.
- You have a confirmed diagnosis of cancer of unknown primary (CUP).
- You are able to carry out most daily activities (ECOG performance status 0 to 2).
- You have a tumor sample (from a past biopsy or surgery) that can be used for testing.
- You are willing to give blood samples on up to two separate occasions.
- You do not have a known HIV, Hepatitis B, or Hepatitis C infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a radioactive drug called Lu-177 FAP-2286 for people with cancer that started in an unknown place (CUP). It may help shrink tumors by targeting a protein found on many cancer cells.
This trial is for people whose cancer started in an unknown place (cancer of unknown primary). It uses a special test called PaCIFiC-CUP to help classify the cancer, which may guide better treatment choices.
This trial is for people with cancer of unknown primary — meaning the cancer has spread, but the original source can't be found. The study aims to better understand these cancers and find more personalized treatments by testing biopsy samples and giving tailored care.
This trial looks at the experiences of people with cancer of unknown primary (CUP) and their caregivers. It aims to understand what it's like to live without a clear diagnosis and how to improve support.
This trial looks at your tumor (and blood) to find helpful targets so doctors can match you to an experimental targeted therapy, if one fits. It may help by using detailed “tumor profiling” to choose treatments more precisely for your cancer.
This trial uses a genetic test on a sample from your metastatic tumor to help identify where your cancer started. It may help guide your treatment decisions.
Hear when a new Cancer of Unknown Primary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.